Rationale and design of the POSTEMI (Postconditioning in ST-Elevation Myocardial Infarction) study

Cardiology

Volumn 116, Issue 2, 2010, Pages 103-109

  Limalanathan, Shanmuganathan ^a,b   Andersen, Geir Øystein ^a,b   Hoffmann, Pavel ^a   Kløw, Nils Einar ^a   Abdelnoor, Michael ^a   Eritsland, Jan ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute myocardial infarction; Cardiac MRI; Percutaneous coronary intervention; Postconditioning; Reperfusion injury; ST elevation

Indexed keywords

BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION PREVENTION; HEART MUSCLE REVASCULARIZATION; METHODOLOGY; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY CIRCULATION; ELECTROCARDIOGRAM PATTERN; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ELECTROCARDIOGRAPHY; RESEARCH DESIGN;

EID: 77953943993     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316965     Document Type: Article

References (29)

1. Fibrinolytic Therapy Trialists (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 100 patients. Lancet 1994;343:311-322.
2. Van de Werf F, Bax J, Betriu A, et al: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008;29:2909-2945.
3. TIMI Study Group: Definitions used in TIMI trials. .
4. Ndrepa G, Mehilli J, Schulz S, et al: Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. J Am Coll Cardiol 2008;52:512-517.
5. Gibson CM, Cannon CP, Murphy SA, et al: Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-130.
6. de Lemos JA, Braunwald E: ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001; 38:1283-1294.
7. Yellon DM, Hausenloy DJ: Myocardial re-perfusion injury. N Engl J Med 2007;357: 1121-1135.
8. Hearse DJ, Bolli R: Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992;26:101-108.
9. Hausenloy DJ, Yellon DM: New directions for protecting the heart against ischemia-re-perfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK) pathway. Cardiovasc Res 2004;61:448-460.
10. Hausenloy DJ, Yellon DM: The mitochondri-al permeability transition pore: its fundamental role in mediating cell death during ischemia and reperfusion. J Mol Cell Cardiol 2003;35: 339-341.
11. Hausenloy DJ, Duchen MR, Yellon DM: Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischemia reperfusion injury. Cardio-vasc Res 2003;60:617-625.
12. Piot C, Croisille P, Staat P, et al: Effect of cy- closporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008; 359: 473-481.
13. Atar D, Petzelbauer P, Schwitter J, et al: Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2009; 53: 720729.
14. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
15. Granfeldt A, Lefer DJ, Vinten-Johansen J: Protective ischemia in patients: preconditioning and postconditioning. Cardiovasc Res 2009; 83:234-246.
16. Zhao ZQ, Corvera JS, Halkos ME, et al: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588.
17. Laskey WK: Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myo-cardial infarction: a pilot study. Cathet Cardiovasc Interven 2005;65:361-367.
18. Staat P, Rifoul G, Piot C, et al: Postcondition- ing the human heart. Circulation 2005; 112: 2143-2148.
19. Thibault H, Piot C, Staat P, et al: Long-term benefit of postconditioning. Circulation 2008;117:1037-1044.
20. Hansen P, Thibault H, Abdulla J: Postcondi-tioning during primary percutaneous coronary intervention: a review and meta-analysis. Int J Cardiol 2009, E-pub ahead of print.
21. Lönborg J, Kelbak H, et al: Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 2010; 3: 34-41.
22. Moher D, Schulz KF, Altman DG; for the CONSORT Group: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:11911194.
23. Gurm HS, Smith DE, Collins JS, et al: The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 2008; 51: 529-535.
24. Hoffmann P, Halvorsen S, Stensaeth KH, et al: Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty. Scand Cardiovasc J 2006;40:96-104.
25. Ganame J, Messalli G, Dymarkowski S, et al: Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 30: 1440-1449.
26. O'Regan DP, Ahmed R, Karunanithy N, et al: Reperfusion hemorrhage following acute myocardial infarction: assessment with T2*mapping and effect on measuring the area at risk. Radiology 2009;250:916-922.
27. Carlsson M, Ubachs JFA, Hedstrom E, Hei-berg E, Jovinge S, Arheden H: Myocardium at risk after acute infarction in humans on cardiac magnetic resonance. J Am Coll Cardiol Img 2009;2: 569-576.
28. Pocock SJ: Clinical Trials: A Practical Approach. Chichester, John Wiley and Sons, 1983.
29. Kalla K, Christ G, Karnik R, et al: Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI Registry). Circulation 2006;113:2398-2405.